Lexeo Therapeutics, Common Stock Price on November 26, 2024
LXEO Stock | 3.38 0.35 9.38% |
If you're considering investing in Lexeo Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lexeo Therapeutics, stands at 3.38, as last reported on the 26th of February, with the highest price reaching 3.83 and the lowest price hitting 3.37 during the day. Lexeo Therapeutics, has Sharpe Ratio of -0.24, which conveys that the firm had a -0.24 % return per unit of risk over the last 3 months. Lexeo Therapeutics, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lexeo Therapeutics,'s Mean Deviation of 4.81, risk adjusted performance of (0.08), and Standard Deviation of 5.83 to check out the risk estimate we provide.
At this time, Lexeo Therapeutics,'s Total Stockholder Equity is very stable compared to the past year. As of the 26th of February 2025, Other Stockholder Equity is likely to grow to about 187.8 M, while Common Stock Shares Outstanding is likely to drop about 27.7 M. . At this time, Lexeo Therapeutics,'s Price Book Value Ratio is very stable compared to the past year. As of the 26th of February 2025, Price To Book Ratio is likely to grow to 2.98, while Price To Sales Ratio is likely to drop 369.18. Lexeo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lexeo |
Sharpe Ratio = -0.2353
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | LXEO |
Estimated Market Risk
5.77 actual daily | 51 51% of assets are less volatile |
Expected Return
-1.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lexeo Therapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lexeo Therapeutics, by adding Lexeo Therapeutics, to a well-diversified portfolio.
Price Book 0.8855 | Enterprise Value Ebitda (6.02) | Shares Float 17 M | Wall Street Target Price 22.43 | Earnings Share (12.53) |
Lexeo Therapeutics, Valuation on November 26, 2024
It is possible to determine the worth of Lexeo Therapeutics, on a given historical date. On November 26, 2024 Lexeo was worth 7.27 at the beginning of the trading date compared to the closed value of 7.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lexeo Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Lexeo Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lexeo Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lexeo Therapeutics,'s related companies.
Open | High | Low | Close | Volume | |
6.53 | 7.28 | 6.53 | 7.23 | 240,288 | |
11/26/2024 | 7.27 | 7.58 | 7.14 | 7.33 | 123,857 |
7.85 | 8.15 | 7.58 | 7.83 | 228,868 |
Backtest Lexeo Therapeutics, | | | Lexeo Therapeutics, History | | | Lexeo Therapeutics, Valuation | Previous | Next |
Lexeo Therapeutics, Trading Date Momentum on November 26, 2024
On November 27 2024 Lexeo Therapeutics, Common was traded for 7.83 at the closing time. The top price for the day was 8.15 and the lowest listed price was 7.58 . The trading volume for the day was 228.9 K. The trading history from November 27, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 6.82% . The trading delta at closing time against the current closing price is 3.41% . |
Lexeo Therapeutics, Fundamentals Correlations and Trends
By evaluating Lexeo Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lexeo Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lexeo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lexeo Therapeutics, Stock history
Lexeo Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lexeo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lexeo Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lexeo Therapeutics, stock prices may prove useful in developing a viable investing in Lexeo Therapeutics,
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 30.6 M | 27.7 M |
Lexeo Therapeutics, Quarterly Net Working Capital |
|
Lexeo Therapeutics, Stock Technical Analysis
Lexeo Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lexeo Therapeutics, Period Price Range
Low | February 26, 2025
| High |
0.00 | 0.00 |
Lexeo Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lexeo Therapeutics, February 26, 2025 Market Strength
Market strength indicators help investors to evaluate how Lexeo Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lexeo Therapeutics, shares will generate the highest return on investment. By undertsting and applying Lexeo Therapeutics, stock market strength indicators, traders can identify Lexeo Therapeutics, Common entry and exit signals to maximize returns
Lexeo Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lexeo Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Lexeo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lexeo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.71) | |||
Total Risk Alpha | (0.75) | |||
Treynor Ratio | (0.58) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexeo Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexeo Therapeutics,. If investors know Lexeo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexeo Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lexeo Therapeutics, is measured differently than its book value, which is the value of Lexeo that is recorded on the company's balance sheet. Investors also form their own opinion of Lexeo Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Lexeo Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexeo Therapeutics,'s market value can be influenced by many factors that don't directly affect Lexeo Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexeo Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Lexeo Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexeo Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.